Table 2

Priority levels assigned to each question by the Executive Guideline Steering Group

High priority*Based on new evidence that could potentially impact the current evidence base, the recommendation is out of date and a high priority for updating, or high priority for development of a new recommendation.
Low priorityNew reports or information are unlikely to impact on current evidence base and no update is planned for this recommendation, or;
An updated search indicates that zero new reports or information are available, the recommendation is up to date and can be revalidated.
Further assessment requiredFor those questions where the group felt they could not make an assessment of high or low priority without further information (such as the contents of new trial reports or locating possible additional reports).
  • *In some instances, updating high priority recommendations needs to be aligned with completion of an ongoing study that is expected to have a significant impact on current recommendation/s and/or clinical practice.